CareRx Statistics

Total Valuation

CareRx has a market cap or net worth of CAD 176.39 million. The enterprise value is 247.71 million.

Market Cap	176.39M
Enterprise Value	247.71M

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

CareRx has 63.00 million shares outstanding. The number of shares has increased by 4.25% in one year.

Current Share Class	63.00M
Shares Outstanding	63.00M
Shares Change (YoY)	+4.25%
Shares Change (QoQ)	+6.98%
Owned by Insiders (%)	1.81%
Owned by Institutions (%)	37.01%
Float	29.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	124.44
PS Ratio	0.48
PB Ratio	2.04
P/TBV Ratio	n/a
P/FCF Ratio	5.97
P/OCF Ratio	4.89
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.83, with an EV/FCF ratio of 8.39.

EV / Earnings	-65.93
EV / Sales	0.68
EV / EBITDA	9.83
EV / EBIT	34.63
EV / FCF	8.39

Financial Position

The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.95.

Current Ratio	1.07
Quick Ratio	0.72
Debt / Equity	0.95
Debt / EBITDA	3.27
Debt / FCF	2.79
Interest Coverage	0.87

Financial Efficiency

Return on equity (ROE) is -4.48% and return on invested capital (ROIC) is 2.57%.

Return on Equity (ROE)	-4.48%
Return on Assets (ROA)	1.98%
Return on Invested Capital (ROIC)	2.57%
Return on Capital Employed (ROCE)	4.40%
Revenue Per Employee	250,024
Profits Per Employee	-2,563
Employee Count	1,508
Asset Turnover	1.62
Inventory Turnover	13.64

Taxes

Income Tax	-440,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.27% in the last 52 weeks. The beta is 0.53, so CareRx's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	+35.27%
50-Day Moving Average	2.73
200-Day Moving Average	2.28
Relative Strength Index (RSI)	51.03
Average Volume (20 Days)	13,490

Short Selling Information

The latest short interest is 865, so 0.00% of the outstanding shares have been sold short.

Short Interest	865
Short Previous Month	1,548
Short % of Shares Out	0.00%
Short % of Float	0.00%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CareRx had revenue of CAD 366.54 million and -3.76 million in losses. Loss per share was -0.06.

Revenue	366.54M
Gross Profit	108.23M
Operating Income	7.15M
Pretax Income	-3.73M
Net Income	-3.76M
EBITDA	21.40M
EBIT	7.15M
Loss Per Share	-0.06

Full Income Statement

Balance Sheet

The company has 11.17 million in cash and 82.49 million in debt, giving a net cash position of -71.32 million or -1.13 per share.

Cash & Cash Equivalents	11.17M
Total Debt	82.49M
Net Cash	-71.32M
Net Cash Per Share	-1.13
Equity (Book Value)	86.40M
Book Value Per Share	1.38
Working Capital	4.15M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 36.09 million and capital expenditures -6.56 million, giving a free cash flow of 29.53 million.

Operating Cash Flow	36.09M
Capital Expenditures	-6.56M
Free Cash Flow	29.53M
FCF Per Share	0.47

Full Cash Flow Statement

Margins

Gross margin is 29.53%, with operating and profit margins of 1.95% and -1.03%.

Gross Margin	29.53%
Operating Margin	1.95%
Pretax Margin	-1.02%
Profit Margin	-1.03%
EBITDA Margin	5.84%
EBIT Margin	1.95%
FCF Margin	8.06%

Dividends & Yields

CareRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.25%
Shareholder Yield	n/a
Earnings Yield	-2.13%
FCF Yield	16.74%

Stock Splits

The last stock split was on June 25, 2020. It was a reverse split with a ratio of 0.05.

Last Split Date	Jun 25, 2020
Split Type	Reverse
Split Ratio	0.05

Scores

CareRx has an Altman Z-Score of 0.55 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.55
Piotroski F-Score	4